A total of 101 patients (87.8%) used prescription lipid-lowering medications, while the others had either stopped taking these drugs (9, 7.8%) or had never been prescribed them (5, 4.3%).

[1] Clinical studies have demonstrated the benefit of lipid-lowering medications in decreasing CHD events in patients receiving treatment for both primary prevention [2,3] and secondary prevention.